ATYR
aTyr Pharma, Inc.
NASDAQ: ATYR · HEALTHCARE · BIOTECHNOLOGY
$0.81
+5.54% today
Updated 2026-04-30
Market cap
$76.98M
P/E ratio
—
P/S ratio
405.16x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$1 – $7
Volume
1.1M
aTyr Pharma, Inc. (ATYR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-40,856.00%
ROE
-108.10%
ROA
-51.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-17.61M | — | — | — |
| 2013 | — | $-20.01M | — | — | — |
| 2014 | — | $-24.35M | — | — | — |
| 2015 | — | $-47.97M | — | — | — |
| 2016 | — | $-57.85M | — | — | — |
| 2017 | — | $-48.21M | — | — | — |
| 2018 | — | $-34.52M | — | — | — |
| 2019 | $422000.00 | $-23.60M | -3,228.91% | -5,445.02% | -5,593.13% |
| 2020 | $10.46M | $-16.22M | -65.38% | -152.19% | -155.18% |
| 2021 | $0.00 | $-33.77M | — | — | — |
| 2022 | $10.39M | $-45.34M | 83.68% | -446.79% | -436.53% |
| 2023 | $353000.00 | $-50.39M | 100.00% | -15,557.79% | -14,274.50% |
| 2024 | $235000.00 | $-64.02M | 100.00% | -28,899.57% | -27,243.83% |
| 2025 | $190000.00 | $-74.12M | -717.37% | -40,856.32% | -39,009.47% |